CELTIC PHARMA HOLDINGS INVESTS IN NOVACTA BIOSYSTEM.: An article from: Biotech Financial Reports

This digital document is an article from Biotech Financial Reports, published by Worldwide Videotex on August 1, 2009. The length of the article is 1032 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: CELTIC PHARMA HOLDINGS INVESTS IN NOVACTA BIOSYSTEM.
Author: Unavailable
Publication:Biotech Financial Reports (Newsletter)
Date: August 1, 2009
Publisher: Worldwide Videotex
Volume: 16 Issue: 8 Page: NA

Distributed by Gale, a part of Cengage Learning